Sort
50,496 grants matching “lung cancer”
The Role of Cripto in the Pathogenesis of Breast and Colon Cancer
$1,042,793David Salomon · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Vaccine and immunotherapy strategies for cancer and viruses causing cancer
$1,042,696Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
A Phase II Trial of ACAPHA in Former Smokers with IEN.
$1,042,339British Columbia Cancer Agency · U01 · FY2002 · CA
Development of a Molecular Assay to Diagnose Malignant Pleural Effusions
$1,041,709Mark A Nelson · Precision Epigenomics, Inc. · R44 · FY2025 · CA
University of California and UT Southwestern D-PDTC
$1,041,580Luis Guillermo Carvajal Carmona · University Of California At Davis · U54 · FY2025 · CA
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
$1,041,309Norman E Breslow · Fred Hutchinson Cancer Research Center · R01 · FY2010 · CA
Regulation Of Intracellular Iron Metabolism
$1,041,298Tracey A. Rouault · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2017 · HD
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
$1,041,188Kevin Michael Haigis · Beth Israel Deaconess Medical Center · U01 · FY2017 · CA
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
$1,041,188Kevin Michael Haigis · Beth Israel Deaconess Medical Center · U01 · FY2018 · CA
ASIAN AMERICAN NETWORK FOR CANCER AWARENESS RESEARCH & TRAINING
$1,041,004Moon S Chen · University Of California At Davis · U01 · FY2007 · CA
Role of the Epitranscriptome in Cancer
$1,040,760Richard I. Gregory · Boston Children'S Hospital · R35 · FY2022 · CA
Role of the Epitranscriptome in Cancer
$1,040,760Richard I. Gregory · Boston Children'S Hospital · R35 · FY2023 · CA
The TGFÃÂÃÂÃÂÃÂÃÂÃÂÃÂò Signaling Pathway in Development and Cancer
$1,040,760Joan Massague · Sloan-Kettering Inst Can Research · R35 · FY2023 · CA
Novel therapeutic development for small cell lung cancer
$1,040,760Charles M Rudin · Sloan-Kettering Inst Can Research · R35 · FY2023 · CA
The TGFÃÂÃÂÃÂÃÂÃÂÃÂÃÂò Signaling Pathway in Development and Cancer
$1,040,760Joan Massague · Sloan-Kettering Inst Can Research · R35 · FY2022 · CA
Novel therapeutic development for small cell lung cancer
$1,040,760Charles M Rudin · Sloan-Kettering Inst Can Research · R35 · FY2022 · CA
NYU Lung Cancer Biomarker Center
$1,040,156William N Rom · New York University School Of Medicine · U01 · FY2007 · CA
Overlapping Airway Basal Cell Transcriptome Reprogramming in COPD and Lung Cancer
$1,039,556Ronald G Crystal · Weill Medical Coll Of Cornell Univ · R01 · FY2014 · HL
Novel Targets for Vaccine Therapy
$1,039,362Claudia Palena · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
RESTORATION OF APOPTOSIS IN CANCER
$1,038,933University Of Texas Md Anderson Can Ctr · P01 · FY2000 · CA
Applying Bioinformatics to Research in Immune, Muscle, and Bone Diseases
$1,038,805Massimo Gadina · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIH · FY2017 · AR
Molecular mechanisms of resistance to TGF-beta signaling
$1,038,566Seong-Jin Kim · Basic Sciences · Z01 · FY2007 · CA
National Resource for Translational and Developmental Proteomics
$1,038,321Neil L Kelleher · Northwestern University · P41 · FY2016 · GM
Multiethnic Genome Scan of Metabolic Phenotypes
$1,037,799Loic Le Marchand · University Of Minnesota · P01 · FY2012 · CA
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
$1,037,336Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA